234 related articles for article (PubMed ID: 18174734)
1. Hypopituitarism oddities: craniopharyngiomas.
Karavitaki N
Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
[TBL] [Abstract][Full Text] [Related]
2. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
[TBL] [Abstract][Full Text] [Related]
3. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
Cannavò S; Marini F; Trimarchi F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
[TBL] [Abstract][Full Text] [Related]
4. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone on pituitary tumour growth.
Herring R; Russell-Jones D
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
Holmer H; Ekman B; Björk J; Nordstöm CH; Popovic V; Siversson A; Erfurth EM
Eur J Endocrinol; 2009 Nov; 161(5):671-9. PubMed ID: 19667040
[TBL] [Abstract][Full Text] [Related]
9. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
[TBL] [Abstract][Full Text] [Related]
10. [Anterior pituitary insufficiencies in children].
Warnet A
Soins; 1989 Mar; (522):9-14. PubMed ID: 2727739
[No Abstract] [Full Text] [Related]
11. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.
Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M
Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341
[TBL] [Abstract][Full Text] [Related]
12. Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors.
Faienza MF; Delvecchio M; Indrio F; Francavilla R; Acquafredda A; Cavallo L
Horm Res; 2009; 71(6):372-5. PubMed ID: 19506396
[TBL] [Abstract][Full Text] [Related]
13. Growth in children with a craniopharyngioma.
Blethen SL
Pediatrician; 1987; 14(4):242-5. PubMed ID: 2840646
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).
Darendeliler F; Karagiannis G; Wilton P; Ranke MB; Albertsson-Wikland K; Anthony Price D; On Behalf Of The Kigs International Board
Acta Paediatr; 2006 Oct; 95(10):1284-90. PubMed ID: 16982503
[TBL] [Abstract][Full Text] [Related]
15. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
[TBL] [Abstract][Full Text] [Related]
17. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
[TBL] [Abstract][Full Text] [Related]
18. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
19. [Pre- and postoperative endocrine function in children with craniopharyngioma ].
Lucas C; Benderitter T; Choux M
Arch Fr Pediatr; 1982 May; 39(5):303-7. PubMed ID: 7125828
[TBL] [Abstract][Full Text] [Related]
20. [Growth hormone deficiency in children and adults].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2005 Nov; 19(113):704-9. PubMed ID: 16498817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
